India, Sept. 23 -- The following biotech stocks reached a 52-week high on September 22, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.
Omeros Corporation (OMER) Omeros Corporation is involved in advancing proteins and small molecule therapies for complement-driven, addictive, or impulsive disorders. The company saw shares rise over 13% to a 52-week high of $21.24 on Tuesday. Omeros markets YARTEMLEA, an FDA-approved treatment for stem cell transplant - associated thrombotic microangiopathy (TA-TMA). In the second quarter of this year, sales of the drug resulted in $32.2 million. The company is additionally developing OMS527 for the treatment of addiction and cocaine use disorder. Alpha Tek...